(Q31426813)

2 July 2017

title

Salicylamide inhibitors of influenza virus fusion (English)

1 reference

ORCID Public Data File 2021

2 July 2017

1 reference

author name string

Combrink KD

1

1 reference

2 July 2017

Gulgeze HB

2

1 reference

2 July 2017

Yu KL

3

1 reference

2 July 2017

Pearce BC

4

1 reference

2 July 2017

Trehan AK

5

1 reference

2 July 2017

Wei J

6

1 reference

2 July 2017

Deshpande M

7

1 reference

2 July 2017

Krystal M

8

1 reference

2 July 2017

Torri A

9

1 reference

2 July 2017

Luo G

10

1 reference

2 July 2017

Cianci C

11

1 reference

2 July 2017

Danetz S

12

1 reference

2 July 2017

Tiley L

13

1 reference

2 July 2017

Meanwell NA

14

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Bioorganic & Medicinal Chemistry Letters

2 July 2017

published in

1 reference

2 July 2017

volume

10

1 reference

2 July 2017

issue

15

1 reference

2 July 2017

page(s)

1649-1652

1 reference

Antiviral therapy: current concepts and practices

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Neuraminidase inhibitors as anti-influenza virus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Characterization of a hemagglutinin-specific inhibitor of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Novel quinolizidine salicylamide influenza fusion inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Cyanohydridoborate anion as a selective reducing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Substituted benzamides with conformationally restricted side chains. 5. Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900335-8

7 January 2021

10.1016/S0960-894X(00)00335-8

Identifiers

DOI

1 reference

2 July 2017

1 reference